Economic Comparison of Percutaneous (pEVAR) vs. Open Access in EVAR. (EVAccess)
Primary Purpose
Aortic Aneurysm
Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
pEVAR
open femoral access
Sponsored by
About this trial
This is an interventional treatment trial for Aortic Aneurysm focused on measuring Endovascular Aortic Repair (EVAR), percutaneous EVAR (pEVAR), cost analysis, procedure time
Eligibility Criteria
Inclusion Criteria:
- Indication for endovascular aortic repair
Exclusion Criteria:
- femoral aneurysm, severe femoral artery calcification, keloided inguinal region, severe obesity, patients diagnosed with Alzheimer's disease or severe psychiatric diagnosis, patient's with occlusive aortic disease
Sites / Locations
- Wilhelminenspital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
pEVAR
open femoral access
Arm Description
percutaneous femoral access using a suture-mediated closure system
cutdown to femoral artery and surgical closure
Outcomes
Primary Outcome Measures
Overall costs of each different access
Overall costs of each different access way including used material and duration of the procedure (shorter duration = less costs of running operation theatre).
Secondary Outcome Measures
Access duration
Separately measured duration of each access way itself (from start until first sheath is applied and from removal of sheath until wound is closed). The duration of endovascular repair is not included.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02822560
Brief Title
Economic Comparison of Percutaneous (pEVAR) vs. Open Access in EVAR.
Acronym
EVAccess
Official Title
Comparative Clinical and Economic Analysis of Percutaneous vs. Open Access for Endovascular Aortic Repair - a Prospective, Randomised Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
July 2016 (Actual)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wilhelminenspital Vienna
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The present clinical trial is performed in the field of vascular surgery. The aim of the study is the economical and clinical comparison of two different access ways to the femoral artery with intention of endovascular repair of aortic aneurysm. The usual access is a surgical cutdown to the femoral artery and is compared to a percutaneous access which is closed via a suture mediated device (Perclose ProGlide, Abbott).
Detailed Description
Introduction:
Endovascular repair of aortic aneurysms (EVAR) is a routine procedure in vascular surgery and associated with less perioperative complications compared to open aortic repair. Continuous improvement of endovascular techniques is crucial for sufficient patient care, especially in elderly with serious comorbidities. Percutaneous access (pEVAR) to the femoral artery is associated with less wound complications when performed in suitable patients. Prospective data about economic feasibility and exact duration of the technique itself compared to the open access during the surgery are missing.
Methods and data collection:
The primary endpoints of this prospective randomised single center trial are cost and time differences of open vs. percutaneous access. Each Patient enrolled in the study will receive percutaneous on one side and surgical access on the other side of the groin for femoral artery access.
The punction site will be closed using the Perclose ProGlide Suture-Mediated Closure System manufactured by Abbott Vascular. This device works through stiff wire guided delivering of a monofilament suture to the femoral artery punction site. After finishing endovascular procedures for aneurysm repair, the thereby laid sutures are tightened to achieve hemostasis. This system is suitable for sheath sizes up to 21 F (.28 inch).
Open access on the other side is performed with a cutdown to the femoral artery and closure after finished procedure, with a polypropylene suture.
Patients who undergo endovascular aortic repair at the Department of Vascular Surgery of Wilhelminenspital Vienna are recruited for the study after informed consent and fulfilled inclusion criteria. Included are men and women from the age of 18 - 90 years with any indication for endovascular aneurysm repair (thoracic, infrarenal aortic or iliac artery aneurysm, or combinations of these). Indication for aneurysm repair is not a part of this study and is set in accordance to international guidelines. Women in childbearing years could be included after detailed explanation of special risks for further pregnancy after EVAR and after proof of negative pregnancy test. Exclusion criteria are occlusive aortic disease, aneurysm of the femoral artery, diameter < 5mm or severe calcification, patients with keloided inguinal site, adipositas per magna or demented patients.
Due to a prior power analysis a optimum number of 50 cases was determined. Randomization is performed by lot (patients draw an envelope which contains either left or right side is done by pEVAR).
Data is collected preoperatively with a case report form (CRF) including detailed health information about the patient. During the surgery, femoral artery access and wound closure time is measured separately for each side (in minutes). Material costs are also documented separately for each side (in €). Postoperative data about wound healing and pain of each inguinal side are collected descriptive using the CRF. Data management and analysis is anonymous using random patient numbers on the forms.
Main targets of the study are cost and time difference of percutaneous and open access techniques. Possible difference in both groups will be analyzed using the Wilcoxon Signed Rank Test. Postoperative data will be evaluated descriptively.
In case of cost advantage of the percutaneous access, this study economically legitimates the use of suture mediated closure systems and therefore contributes to the establishment of minimally invasive endovascular aortic repair.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm
Keywords
Endovascular Aortic Repair (EVAR), percutaneous EVAR (pEVAR), cost analysis, procedure time
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
pEVAR
Arm Type
Active Comparator
Arm Description
percutaneous femoral access using a suture-mediated closure system
Arm Title
open femoral access
Arm Type
Active Comparator
Arm Description
cutdown to femoral artery and surgical closure
Intervention Type
Device
Intervention Name(s)
pEVAR
Intervention Description
percutaneous femoral access using a suture-mediated closure device
Intervention Type
Procedure
Intervention Name(s)
open femoral access
Intervention Description
cutdown to femoral artery and surgical closure
Primary Outcome Measure Information:
Title
Overall costs of each different access
Description
Overall costs of each different access way including used material and duration of the procedure (shorter duration = less costs of running operation theatre).
Time Frame
During surgery
Secondary Outcome Measure Information:
Title
Access duration
Description
Separately measured duration of each access way itself (from start until first sheath is applied and from removal of sheath until wound is closed). The duration of endovascular repair is not included.
Time Frame
During surgery
Other Pre-specified Outcome Measures:
Title
Wound complications
Description
Descriptive analysis of wound healing and complications after open vs. percutaneous access in the same individual.
Time Frame
up to 10 days postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Indication for endovascular aortic repair
Exclusion Criteria:
femoral aneurysm, severe femoral artery calcification, keloided inguinal region, severe obesity, patients diagnosed with Alzheimer's disease or severe psychiatric diagnosis, patient's with occlusive aortic disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Afshin Assadian, PD, MD
Organizational Affiliation
Wilhelminenspital Vienna
Official's Role
Study Director
Facility Information:
Facility Name
Wilhelminenspital
City
Vienna
ZIP/Postal Code
1160
Country
Austria
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
Patient characteristics (gender, age, body mass index, earlier operations, written wound documentation etc.), operation time, material and overall procedure costs.
Citations:
PubMed Identifier
29526378
Citation
Uhlmann ME, Walter C, Taher F, Plimon M, Falkensammer J, Assadian A. Successful percutaneous access for endovascular aneurysm repair is significantly cheaper than femoral cutdown in a prospective randomized trial. J Vasc Surg. 2018 Aug;68(2):384-391. doi: 10.1016/j.jvs.2017.12.052. Epub 2018 Mar 8.
Results Reference
derived
Learn more about this trial
Economic Comparison of Percutaneous (pEVAR) vs. Open Access in EVAR.
We'll reach out to this number within 24 hrs